SF Medical ApS — Credit Rating and Financial Key Figures
Credit rating
Company information
About SF Medical ApS
SF Medical ApS (CVR number: 36964901) is a company from RUDERSDAL. The company recorded a gross profit of -81.1 kDKK in 2023. The operating profit was -225.1 kDKK, while net earnings were -234.3 kDKK. The profitability of the company measured by Return on Assets (ROA) was -56.1 %, which can be considered poor and Return on Equity (ROE) was -85.7 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 40.1 %, a level that can be considered to be modest. This means a balanced mix of debt and equity financing its assets—a typical operational level for many companies. SF Medical ApS's liquidity measured by quick ratio was 17.3 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.
Financial information
See financialsGross profit (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Volume | |||||
Net sales | |||||
Gross profit | - 149.84 | - 208.98 | - 253.66 | -17.21 | -81.06 |
EBIT | - 464.84 | - 401.02 | - 433.66 | - 375.04 | - 225.06 |
Net earnings | - 385.37 | - 333.13 | - 357.02 | - 319.61 | - 234.26 |
Shareholders equity total | 79.06 | 95.93 | - 261.09 | 390.33 | 156.06 |
Balance sheet total (assets) | 644.29 | 529.36 | 534.67 | 405.33 | 389.47 |
Net debt | 539.16 | 408.31 | 766.62 | -19.44 | 206.30 |
Profitability | |||||
EBIT-% | |||||
ROA | -72.8 % | -68.3 % | -65.5 % | -62.4 % | -56.1 % |
ROE | -537.1 % | -380.7 % | -113.2 % | -69.1 % | -85.7 % |
ROI | -77.5 % | -70.1 % | -67.4 % | -64.5 % | -58.9 % |
Economic value added (EVA) | - 365.94 | - 316.22 | - 342.57 | - 279.15 | - 250.21 |
Solvency | |||||
Equity ratio | 12.3 % | 18.1 % | -32.8 % | 96.3 % | 40.1 % |
Gearing | 695.9 % | 436.2 % | -295.6 % | 135.1 % | |
Relative net indebtedness % | |||||
Liquidity | |||||
Quick ratio | 38.7 | 31.2 | 19.4 | 27.0 | 17.3 |
Current ratio | 42.8 | 35.3 | 22.3 | 27.0 | 17.3 |
Cash and cash equivalents | 11.03 | 10.12 | 5.15 | 19.44 | 4.59 |
Capital use efficiency | |||||
Trade debtors turnover (days) | |||||
Net working capital % | |||||
Credit risk | |||||
Credit rating | BB | BB | BB | BB | BB |
Variable visualization
Roles
Companies in the same industry
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.